Hematology/Oncology

Top Story

Most adolescents, young adults with leukemia subtype treated with therapies meant for adults

December 15, 2017

Read the Perspective from Amelia A. Langston, MD

ATLANTA — The number of adolescents and young adults with acute lymphoblastic leukemia treated with pediatric-inspired chemotherapy regimens appears to be quite low, according to results from the California Cancer Registry presented at the ASH Annual Meeting and Exposition.

“Abundant evidence suggests that [adolescents and young adults] with ALL have improved outcomes when treated following pediatric-inspired, as opposed to adult, ALL chemotherapy regimens,” the researchers wrote. “Given the complexity of pediatric ALL protocols, it is unclear whether this approach has been universally accepted by medical oncologists treating [adolescent and young adult patients with ALL] across the population.”

Meeting NewsVideo

VIDEO: Studies may lead to ‘era’ where chemotherapy is not needed for lymphoma subtype

December 15, 2017
ATLANTA — Two long-term follow-up studies presented at the ASH Annual Meeting and Exposition may indicate a future where patients with mantle cell lymphoma can be…
In the Journals Plus

Men with HPV16 at 20-fold increased risk for reinfection after 1 year

December 15, 2017
Men infected with HPV16 — the strain responsible for most HPV-related cancers — were 20 times more likely to be reinfected with the same type after 1 year…
Meeting News

Older adults underrepresented in clinical trials for blood cancers

December 15, 2017
ATLANTA — Although adults aged 65 to 74 years appeared adequately represented in hematologic malignancy clinical trials between 2005 and 2015, those aged 75 years…

FDA continues to caution against use of power morcellators

December 15, 2017
In an updated assessment, the FDA warned against the use of laparoscopic power morcellators for the majority of women undergoing myomectomy or hysterectomy for treatment…
More Headlines »
CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed…
More »
Video
Meeting News

VIDEO: Symposium offers research, mentorship opportunities

November 3, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium

CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement